Vicente Anido, Jr.
2020
In 2020, Vicente Anido, Jr. earned a total compensation of $3.6M as Chief Executive Officer and Chairman of the Board at Aerie Pharmaceuticals, a 35% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $521,326 |
|---|---|
| Option Awards | $1,710,048 |
| Salary | $795,675 |
| Stock Awards | $593,040 |
| Total | $3,620,089 |
Anido received $1.7M in option awards, accounting for 47% of the total pay in 2020.
Anido also received $521.3K in non-equity incentive plan, $795.7K in salary and $593K in stock awards.
Rankings
In 2020, Vicente Anido, Jr.'s compensation ranked 3,207th out of 13,090 executives tracked by ExecPay. In other words, Anido earned more than 75.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,207 out of 13,090 | 76th |
Division Manufacturing | 1,248 out of 5,621 | 78th |
Major group Chemicals And Allied Products | 474 out of 2,254 | 79th |
Industry group Drugs | 410 out of 1,954 | 79th |
Industry Biological Products, Except Diagnostic Substances | 103 out of 411 | 75th |
Source: SEC filing on April 27, 2021.
Anido's colleagues
We found five more compensation records of executives who worked with Vicente Anido, Jr. at Aerie Pharmaceuticals in 2020.
2020
Thomas Mitro
Aerie Pharmaceuticals
Chief Operating Officer
2020
Richard Rubino
Aerie Pharmaceuticals
Chief Financial Officer
2020
Casey Kopczynski
Aerie Pharmaceuticals
Chief Scientific Officer
2020
John LaRocca
Aerie Pharmaceuticals
General Counsel
2020
David Hollander
Aerie Pharmaceuticals
Chief Research and Development Officer
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019